Cao Tanze, Liu Xiuping, Yang Chengqing, Mei Chunlin, Ou Jiali, Du Ronghui
Department of Respiratory and Critical Care Medicine, Wuhan Pulmonary Hospital, Wuhan 430030, China.
J Clin Tuberc Other Mycobact Dis. 2023 Feb 27;31:100355. doi: 10.1016/j.jctube.2023.100355. eCollection 2023 May.
Tuberculosis (TB) continues to be a common disease in developing countries, among which middle ear TB is rare. Furthermore, it is relatively difficult to make an early diagnosis and provide follow-up treatment for middle ear TB. So, it is necessary to report this case for reference and further discussion.
We reported 1 case of multidrug-resistant tuberculosis otitis media. TB otitis media is rare in tuberculosis; multidrug-resistant TB otitis media is even more rare. Our paper analyzes the possible causes, imaging, molecular biology, pathology, and clinical manifestations of multidrug-resistant TB otitis media.
PCR and DNA molecular biology techniques are highly recommended for the early diagnosis of multidrug-resistant TB otitis media. Early, effective anti-tuberculosis treatment is the guarantee for further recovery for patients with multidrug-resistant TB otitis media.
结核病在发展中国家仍然是一种常见疾病，其中中耳结核较为罕见。此外，中耳结核的早期诊断和后续治疗相对困难。因此，有必要报告此病例以供参考和进一步讨论。
我们报告了1例耐多药结核性中耳炎病例。结核性中耳炎在结核病中较为罕见；耐多药结核性中耳炎更为罕见。我们的论文分析了耐多药结核性中耳炎的可能病因、影像学表现、分子生物学特征、病理学特征及临床表现。
强烈推荐采用PCR和DNA分子生物学技术对耐多药结核性中耳炎进行早期诊断。早期、有效的抗结核治疗是耐多药结核性中耳炎患者进一步康复的保证。
